RC
MRK icon

Rovin Capital’s Merck MRK Stock Holding History

Rovin Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.28M Buy
12,202
+5,829
+91% +$547K 0.34% 66
2025
Q3 		$535K Buy
6,373
+2,254
+55% +$186K 0.15% 113
2025
Q2 		$326K Buy
4,119
+732
+22% +$58.2K 0.1% 154
2025
Q1 		$304K Buy
3,387
+460
+16% +$42.9K 0.1% 148
2024
Q4 		$291K Buy
2,927
+1,158
+65% +$119K 0.1% 135
2024
Q3 		$201K Buy
1,769
+36
+2% +$4.28K 0.07% 166
2024
Q2 		$215K Sell
1,733
-209
-11% -$26.9K 0.09% 157
2024
Q1 		$256K Buy
+1,942
New +$239K 0.1% 138
2023
Q3 		– Sell
-1,887
Closed -$218K – 138
2023
Q2 		$218K Sell
1,887
-20
-1% -$2.27K 0.1% 125
2023
Q1 		$203K Sell
1,907
-158
-8% -$17.1K 0.1% 127
2022
Q4 		$229K Sell
2,065
-3,779
-65% -$386K 0.11% 116
2022
Q3 		$503K Buy
5,844
+405
+7% +$36.2K 0.29% 56
2022
Q2 		$496K Sell
5,439
-3,405
-39% -$302K 0.33% 60
2022
Q1 		$726K Buy
8,844
+82
+0.9% +$6.46K 0.39% 38
2021
Q4 		$671K Buy
+8,762
New +$698K 0.32% 47

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rovin Capital's MRK Position: Q4 2025 in Review

Rovin Capital increased its Merck (MRK) stake by 91% in Q4 2025, buying an estimated $547K and bringing the position to 12,202 shares worth $1.28M. The position accounts for 0.34% of the portfolio, ranked #66.

Rovin Capital first reported a position in MRK in Q4 2021 and has held it in 15 quarters since. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Rovin Capital held 12,202 shares of Merck worth $1.28M as of Q4 2025.
  • Rovin Capital bought 5,829 Merck shares in Q4 2025, an estimated $547K.
  • Merck made up 0.34% of Rovin Capital's portfolio in Q4 2025, its #66 holding.
  • Rovin Capital first reported a position in Merck in Q4 2021 and has held it in 15 quarters since.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.